David M. Schwope

Identification of Recent Cannabis Use: Whole-Blood and Plasma Free and Glucuronidated Cannabinoid Pharmacokinetics following Controlled Smoked Cannabis Administration

David M. Schwope, Erin L Karschner, David A. Gorelick et al. · Clinical Chemistry · 2011 · 188 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Δ9-Tetrahydrocannabinol (THC), 11-Hydroxy-THC, and 11-Nor-9-carboxy-THC Plasma Pharmacokinetics during and after Continuous High-Dose Oral THC

Eugene W Schwilke, David M. Schwope, Erin L Karschner et al. · Clinical Chemistry · 2009 · 116 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +7

Psychomotor Performance, Subjective and Physiological Effects and Whole Blood  9-Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis

David M. Schwope, Wendy M. Bosker, Johannes G. Ramaekers et al. · Journal of Analytical Toxicology · 2012 · 101 citations · Full text

Medicine, Pharmacology, Toxicology +16

Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography–tandem mass spectrometry

David M. Schwope, Karl B. Scheidweiler, Marilyn A. Huestis · Analytical and Bioanalytical Chemistry · 2011 · 98 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +12

Tolerance to Effects of High-Dose Oral Δ9-Tetrahydrocannabinol and Plasma Cannabinoid Concentrations in Male Daily Cannabis Smokers

David A. Gorelick, Robert S. Goodwin, Eugene W Schwilke et al. · Journal of Analytical Toxicology · 2012 · 84 citations · Full text

Medicine, Pharmacology, Neuropharmacology +14